Sakamoto H, Sakamoto N, Oryu M, Kobayashi T, Ogawa Y, Ueno M, Shinnou M
2nd Department of Pathology, Kagawa Medical University, Miki-cho, Kita-gun, Japan.
Biochem Biophys Res Commun. 1997 Jan 13;230(2):270-4. doi: 10.1006/bbrc.1996.5935.
Macromolecular activators of phagocytosis from platelets (MAPP:s-MAPP, 1500kDa and 1-MAPP, 300kDa) are glycoproteins released from human platelets and activate leukocyte phagocytosis via the Fc gamma receptors. Their production can be shown in CPD-stored platelets which have lost MAPP releasing activity by incubation with plasma-derived precursos of MAPP (pre-MAPP : pre-s-MAPP, 150kDa and pre-l-MAPP, 300kDa) in the presence of Ca++. Partial amino acid sequence analysis of s-MAPP revealed that it had homogeneity with transferrin (TF). Affinity chromatography using anti TF immunosorbent column showed that all of pre-MAPP and MAPP had immunoreactivity with anti TF antibodies. S-MAPP and 1-MAPP rich preparations from platelet release products lost their activity after treatment with ATP at acidic pH, in which condition iron atoms could be removed from holo-transferrin molecules. In the experiment using polymerized TF and stored platelets, it was shown that platelets incubated with dimer and tetramer TF could produce MAPP function. These results suggest that dimer and tetramer transferrin are precursors of s-MAPP and 1-MAPP, respectively and that iron atoms are necessary for their phagocytosis activating function.
血小板来源的吞噬作用大分子激活剂(MAPP:s-MAPP,1500kDa;1-MAPP,300kDa)是从人血小板中释放的糖蛋白,通过Fcγ受体激活白细胞吞噬作用。它们的产生可在CPD保存的血小板中显示,这些血小板通过在Ca++存在下与血浆来源的MAPP前体(前MAPP:前s-MAPP,150kDa;前1-MAPP,300kDa)孵育而失去了MAPP释放活性。s-MAPP的部分氨基酸序列分析显示它与转铁蛋白(TF)具有同源性。使用抗TF免疫吸附柱的亲和层析表明,所有前MAPP和MAPP都与抗TF抗体具有免疫反应性。血小板释放产物中富含s-MAPP和1-MAPP的制剂在酸性pH条件下用ATP处理后失去活性,在这种条件下铁原子可从全转铁蛋白分子中去除。在使用聚合TF和保存血小板的实验中,结果表明与二聚体和四聚体TF孵育的血小板可产生MAPP功能。这些结果表明,二聚体和四聚体转铁蛋白分别是s-MAPP和1-MAPP的前体,并且铁原子对于它们的吞噬激活功能是必需的。